In an attempt to identify the contribution of epigenetic changes (inactivation) of HLA-DRB5 and/or HLA-DRB1 to the severity of MS, MS patients were classified according to MS severity, based on EDSS score and MS type [32]. This evidence concerns the gene HLA-DRB5 and myeloid sarcoma.